Literature DB >> 11782558

Macrophage migration inhibitory factor.

John A Baugh1, Richard Bucala.   

Abstract

Macrophage migration inhibitory factor (MIF) has been proposed to be the physiologic counter-regulator of glucocorticoid action within the immune system. In this role, MIF's position within the cytokine cascade is to act in concert with glucocorticoids to control both the "set point" and the magnitude of the inflammatory response. As well as overriding the immunosuppressive effects of glucocorticoids, it is now well established that MIF has a direct proinflammatory role in inflammatory diseases, such as sepsis, rheumatoid arthritis, and glomerulonephritis. The functions of MIF within the immune system are both unique and diverse, and although a unified molecular mechanism of action remains to be elucidated, there have been significant advances in our understanding of how MIF affects cellular processes. This review discusses the pathogenic role of MIF in inflammatory disease and highlights the novel structural, functional, and mechanistic properties of MIF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782558

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  48 in total

1.  The effects of melatonin on liver functions in arsenic-induced liver damage.

Authors:  İlhan Bali; Bülent Bilir; Seyfi Emir; Filiz Turan; Ahsen Yılmaz; Tuba Gökkuş; Murat Aydın
Journal:  Ulus Cerrahi Derg       Date:  2016-10-27

2.  Increased Expression of Macrophage Migration Inhibitory Factor in the Nucleus of the Solitary Tract Attenuates Renovascular Hypertension in Rats.

Authors:  Rafaela Moreira Barbosa; Guilherme F Speretta; Daniel Penteado Martins Dias; Prashant Jay Ruchaya; Hongwei Li; José Vanderlei Menani; Colin Sumners; Eduardo Colombari; Débora S A Colombari
Journal:  Am J Hypertens       Date:  2017-04-01       Impact factor: 2.689

3.  Macrophage migration inhibitory factor homolog from Plasmodium yoelii modulates monocyte recruitment and activation in spleen during infection.

Authors:  Yanhui Zhang; Kazutoyo Miura; Jian Li; Gregory Tullo; Feng Zhu; Lingxian Hong; Tianlong Lin; Xin-zhuan Su; Carole Long
Journal:  Parasitol Res       Date:  2011-10-22       Impact factor: 2.289

Review 4.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

5.  Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI.

Authors:  Chengjie Xiong; Bo Huang; Yanping Cun; Bayan G Aghdasi; Yue Zhou
Journal:  Clin Orthop Relat Res       Date:  2014-02-26       Impact factor: 4.176

6.  Charge heterogeneity of bovine brain macrophage migration inhibitory factor.

Authors:  O A Cherepkova; E M Lutova; B Ya Gurvits
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

7.  Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.

Authors:  Chia-Chang Chuang; Yin-Ching Chuang; Wen-Teng Chang; Chi-Chung Chen; Lien-I Hor; A-Ming Huang; Pui-Ching Choi; Chi-Yun Wang; Po-Chin Tseng; Chiou-Feng Lin
Journal:  BMC Immunol       Date:  2010-10-12       Impact factor: 3.615

Review 8.  Integrating genomic and clinical medicine: searching for susceptibility genes in complex lung diseases.

Authors:  Ankit A Desai; Pirro Hysi; Joe G N Garcia
Journal:  Transl Res       Date:  2007-12-18       Impact factor: 7.012

9.  A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study.

Authors:  Lutz E Lehmann; Malte Book; Wolfgang Hartmann; Stefan U Weber; Jens-Christian Schewe; Sven Klaschik; Andreas Hoeft; Frank Stüber
Journal:  J Transl Med       Date:  2009-11-26       Impact factor: 5.531

10.  Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis.

Authors:  W Joost Wiersinga; Thierry Calandra; Liesbeth M Kager; Gerritje J W van der Windt; Thierry Roger; Didier le Roy; Sandrine Florquin; Sharon J Peacock; Fred C G J Sweep; Tom van der Poll
Journal:  PLoS Negl Trop Dis       Date:  2010-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.